Verition Fund Management
EXAS

Verition Fund Management’s Exact Sciences EXAS Stock Holding History

Verition Fund Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,234,379
Closed -$125M – 2689
2025
Q4 		$125M Buy
1,234,379
+1,154,877
+1,453% +$92.7M 0.49% 21
2025
Q3 		$4.35M Sell
79,502
-52,380
-40% -$2.62M 0.02% 1297
2025
Q2 		$7.01M Buy
131,882
+32,619
+33% +$1.66M 0.03% 784
2025
Q1 		$4.3M Buy
99,263
+86,256
+663% +$4.37M 0.02% 961
2024
Q4 		$731K Sell
13,007
-27,808
-68% -$1.73M ﹤0.01% 2237
2024
Q3 		$2.78M Buy
40,815
+35,889
+729% +$2.03M 0.01% 1217
2024
Q2 		$208K Buy
4,926
+327
+7% +$18K ﹤0.01% 2571
2024
Q1 		$318K Buy
4,599
+356
+8% +$22.5K ﹤0.01% 2269
2023
Q4 		$314K Buy
+4,243
New +$278K ﹤0.01% 1781
2023
Q3 		– Sell
-3,181
Closed -$299K – 2443
2023
Q2 		$299K Sell
3,181
-4,819
-60% -$376K ﹤0.01% 1559
2023
Q1 		$542K Buy
+8,000
New +$514K 0.01% 1195
2022
Q4 		– Sell
-30,133
Closed -$979K – 2330
2022
Q3 		$979K Buy
30,133
+11,485
+62% +$474K 0.01% 1418
2022
Q2 		$735K Buy
18,648
+14,095
+310% +$754K 0.01% 1204
2022
Q1 		$318K Buy
4,553
+390
+9% +$28.5K ﹤0.01% 2123
2021
Q4 		$324K Buy
4,163
+1,026
+33% +$90.5K ﹤0.01% 1943
2021
Q3 		$299K Buy
+3,137
New +$331K ﹤0.01% 1471
2020
Q3 		– Sell
-24,861
Closed -$2.16M – 1155
2020
Q2 		$2.16M Buy
24,861
+2,712
+12% +$217K 0.07% 211
2020
Q1 		$1.28M Buy
+22,149
New +$1.8M 0.05% 211
2019
Q4 		– Sell
-6,155
Closed -$556K – 1159
2019
Q3 		$556K Buy
+6,155
New +$701K 0.02% 588
2019
Q2 		– Sell
-8,724
Closed -$756K – 1158
2019
Q1 		$756K Buy
+8,724
New +$743K 0.03% 503
2018
Q4 		– Sell
-12,954
Closed -$1.02M – 942
2018
Q3 		$1.02M Buy
12,954
+2,010
+18% +$131K 0.04% 560
2018
Q2 		$654K Buy
+10,944
New +$589K 0.04% 580

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Verition Fund Management's EXAS Position: Q1 2026 in Review

Verition Fund Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 1,234,379 shares — an estimated $125M sold.

Verition Fund Management first reported a position in EXAS in Q2 2018 and held it in 22 quarters. The position peaked at $125M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Verition Fund Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Verition Fund Management sold 1,234,379 Exact Sciences shares in Q1 2026, an estimated $125M.
  • Verition Fund Management first reported a position in Exact Sciences in Q2 2018 and held it in 22 quarters.
  • Verition Fund Management's Exact Sciences position peaked at $125M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.